NO304889B1 - Imidazopyridiner og deres anvendelse ved fremstilling av legemidler til behandling av mave-tarm-sykdommer - Google Patents

Imidazopyridiner og deres anvendelse ved fremstilling av legemidler til behandling av mave-tarm-sykdommer

Info

Publication number
NO304889B1
NO304889B1 NO953187A NO953187A NO304889B1 NO 304889 B1 NO304889 B1 NO 304889B1 NO 953187 A NO953187 A NO 953187A NO 953187 A NO953187 A NO 953187A NO 304889 B1 NO304889 B1 NO 304889B1
Authority
NO
Norway
Prior art keywords
imidazopyridines
medicines
preparation
treatment
pct
Prior art date
Application number
NO953187A
Other languages
English (en)
Norwegian (no)
Other versions
NO953187L (no
NO953187D0 (no
Inventor
Stefan Postius
Richard Riedel
Wolfgang-Alexander Simon
Joerg Senn-Bilfinger
Gerhard Grundler
Georg Rainer
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of NO953187L publication Critical patent/NO953187L/no
Publication of NO953187D0 publication Critical patent/NO953187D0/no
Publication of NO304889B1 publication Critical patent/NO304889B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO953187A 1993-02-15 1995-08-14 Imidazopyridiner og deres anvendelse ved fremstilling av legemidler til behandling av mave-tarm-sykdommer NO304889B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH45393 1993-02-15
CH194593 1993-06-29
PCT/EP1994/000335 WO1994018199A1 (de) 1993-02-15 1994-02-07 Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten

Publications (3)

Publication Number Publication Date
NO953187L NO953187L (no) 1995-08-14
NO953187D0 NO953187D0 (no) 1995-08-14
NO304889B1 true NO304889B1 (no) 1999-03-01

Family

ID=25684624

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953187A NO304889B1 (no) 1993-02-15 1995-08-14 Imidazopyridiner og deres anvendelse ved fremstilling av legemidler til behandling av mave-tarm-sykdommer

Country Status (29)

Country Link
US (1) US5665730A (cs)
EP (1) EP0683780B1 (cs)
JP (1) JP3447292B2 (cs)
KR (1) KR100297057B1 (cs)
CN (1) CN1052005C (cs)
AT (1) ATE192151T1 (cs)
AU (1) AU678434B2 (cs)
BG (1) BG62773B1 (cs)
CA (1) CA2156078C (cs)
CZ (1) CZ287313B6 (cs)
DE (1) DE59409312D1 (cs)
DK (1) DK0683780T3 (cs)
ES (1) ES2148317T3 (cs)
FI (1) FI109537B (cs)
GR (1) GR3033846T3 (cs)
HU (1) HU219395B (cs)
IL (1) IL108520A (cs)
MY (1) MY111201A (cs)
NO (1) NO304889B1 (cs)
NZ (1) NZ261579A (cs)
PL (1) PL175932B1 (cs)
PT (1) PT683780E (cs)
RO (1) RO117917B1 (cs)
RU (1) RU2136682C1 (cs)
SG (1) SG55184A1 (cs)
SK (1) SK280822B6 (cs)
TW (1) TW293008B (cs)
UA (1) UA43841C2 (cs)
WO (1) WO1994018199A1 (cs)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2191979A1 (en) * 1994-06-20 1995-12-28 Muneo Takatani Condensed imidazole compounds, their production and use
SK197A3 (en) * 1994-07-28 1997-06-04 Byk Gulden Lomberg Chem Fab Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
WO1996003403A1 (de) * 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzylimidazopyridine
AU3343295A (en) * 1994-08-12 1996-03-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridine salt
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
JP2949474B2 (ja) * 1995-08-28 1999-09-13 隆久 古田 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法
DE59712297D1 (de) * 1996-01-26 2005-06-09 Altana Pharma Ag 3-alkylimidazopyridine
DE19602855A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue 3-Methylimidazopyridine
WO1997027193A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogenimidazopyridine
DE69823493T2 (de) * 1997-03-24 2009-09-24 Nycomed Gmbh Tetrahydropyridoverbindungen
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
SE9802794D0 (sv) 1998-08-21 1998-08-21 Astra Ab New compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AU3966600A (en) * 1999-04-17 2000-11-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Haloalkoxy imidazonaphthyridines
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10145457A1 (de) * 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
AR043063A1 (es) * 2002-12-13 2005-07-13 Altana Pharma Ag Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
AR049168A1 (es) * 2004-05-18 2006-07-05 Altana Pharma Ag Derivados de benzimidazol
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
WO1986003720A1 (en) * 1984-12-14 1986-07-03 Moebius Ulrich Ski binding
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
US4831041A (en) * 1986-11-26 1989-05-16 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound

Also Published As

Publication number Publication date
KR960701051A (ko) 1996-02-24
ES2148317T3 (es) 2000-10-16
US5665730A (en) 1997-09-09
KR100297057B1 (ko) 2001-10-24
CZ208895A3 (en) 1995-12-13
MY111201A (en) 1999-09-30
EP0683780A1 (de) 1995-11-29
FI953838A (fi) 1995-09-06
BG62773B1 (bg) 2000-07-31
ATE192151T1 (de) 2000-05-15
NO953187L (no) 1995-08-14
NO953187D0 (no) 1995-08-14
HUT72436A (en) 1996-04-29
HU219395B (hu) 2001-04-28
DK0683780T3 (da) 2000-09-25
NZ261579A (en) 1997-03-24
SK99795A3 (en) 1995-12-06
CZ287313B6 (en) 2000-10-11
JPH08506333A (ja) 1996-07-09
PL175932B1 (pl) 1999-03-31
BG99855A (bg) 1996-04-30
RO117917B1 (ro) 2002-09-30
EP0683780B1 (de) 2000-04-26
UA43841C2 (uk) 2002-01-15
RU2136682C1 (ru) 1999-09-10
WO1994018199A1 (de) 1994-08-18
FI953838A0 (fi) 1995-08-14
AU6039194A (en) 1994-08-29
SK280822B6 (sk) 2000-08-14
GR3033846T3 (en) 2000-10-31
SG55184A1 (en) 1998-12-21
PT683780E (pt) 2000-10-31
CN1052005C (zh) 2000-05-03
AU678434B2 (en) 1997-05-29
TW293008B (cs) 1996-12-11
PL310171A1 (en) 1995-11-27
CA2156078C (en) 2005-02-01
JP3447292B2 (ja) 2003-09-16
CA2156078A1 (en) 1994-08-18
IL108520A0 (en) 1994-05-30
IL108520A (en) 1997-09-30
DE59409312D1 (de) 2000-05-31
CN1119863A (zh) 1996-04-03
FI109537B (fi) 2002-08-30

Similar Documents

Publication Publication Date Title
NO304889B1 (no) Imidazopyridiner og deres anvendelse ved fremstilling av legemidler til behandling av mave-tarm-sykdommer
DZ1794A1 (fr) Nouvelle formule pharmaceutique.
EE03262B1 (et) Imidaso[1,2-a]püridiinidest saadavad alkoksüalküülkarbamaadid, nende valmistamine ja kasutamine
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
DK0675895T3 (da) Etoposidderivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel og anvendelse deraf til fremstilling af et lægemiddel til anticancerbehandling
EE03123B1 (et) Kinoliini derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
DE59307796D1 (de) Entzündungshemmende makrolactame (cyclamenol)
ES2123796T3 (es) Derivados de acidos fosfono-succinicos y su utilizacion como medicamentos.